Posted on March 2, 20253/2/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
Posted on February 27, 20252/27/25
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
Posted on February 21, 20252/21/25
Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficiency
Posted on January 6, 20251/6/25
Beyond Theory: Integrated Commercialization Model Proves Valuable in Launch Success
Posted on November 12, 202411/12/24
Finding the Human Element Amid the Algorithms
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on September 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on August 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on August 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on July 17, 20247/17/24